Form 8-K - Current report:
SEC Accession No. 0001558370-23-009116
Filing Date
2023-05-10
Accepted
2023-05-10 16:20:42
Documents
14
Period of Report
2023-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20230510x8k.htm   iXBRL 8-K 35901
2 EX-99.1 gbio-20230510xex99d1.htm EX-99.1 74900
3 GRAPHIC gbio-20230510xex99d1001.jpg GRAPHIC 6132
  Complete submission text file 0001558370-23-009116.txt   241890

Data Files

Seq Description Document Type Size
4 EX-101.SCH gbio-20230510.xsd EX-101.SCH 3110
5 EX-101.LAB gbio-20230510_lab.xml EX-101.LAB 12476
6 EX-101.PRE gbio-20230510_pre.xml EX-101.PRE 10754
8 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20230510x8k_htm.xml XML 4662
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 23906726
SIC: 2834 Pharmaceutical Preparations